UK's CMA may accept Synopsys/Ansys deal remedies

Investing.com -- The UK's Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS ) and Ansys (NASDAQ:ANSS ). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com